These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 8360655

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Equipment and organization of a frozen tissue bank--an update.
    Naber SP, Andreis CM.
    Verh Dtsch Ges Pathol; 1994; 78():153-60. PubMed ID: 7533978
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
    Gilmore CP, Geurts JJ, Evangelou N, Bot JC, van Schijndel RA, Pouwels PJ, Barkhof F, Bö L.
    Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
    [Abstract] [Full Text] [Related]

  • 26. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA.
    J Neuroimaging; 2005 Feb; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research.
    Watson PH, Snell L, Parisien M.
    CMAJ; 1996 Aug 01; 155(3):281-3. PubMed ID: 8705906
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
    Moll NM, Hong E, Fauveau M, Naruse M, Kerninon C, Tepavcevic V, Klopstein A, Seilhean D, Chew LJ, Gallo V, Nait Oumesmar B.
    Glia; 2013 Oct 01; 61(10):1659-72. PubMed ID: 23918253
    [Abstract] [Full Text] [Related]

  • 31. Ethical aspects to be considered in brain banking.
    Cruz-Sánchez FF, Mordini E, Ravid R.
    Ann Ist Super Sanita; 1997 Oct 01; 33(4):477-82. PubMed ID: 9616957
    [Abstract] [Full Text] [Related]

  • 32. Assessing tissue damage in multiple sclerosis: a biomarker approach.
    Burman J, Zetterberg H, Fransson M, Loskog AS, Raininko R, Fagius J.
    Acta Neurol Scand; 2014 Aug 01; 130(2):81-9. PubMed ID: 24571714
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord.
    Scalabrino G, Veber D, De Giuseppe R, Roncaroli F.
    Neuroscience; 2015 Jul 09; 298():293-301. PubMed ID: 25888933
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 09; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 37. Magnetic resonance imaging of grey matter damage in people with MS.
    Filippi M, Valsasina P, Rocca M.
    Int MS J; 2007 Mar 09; 14(1):12-21. PubMed ID: 17509248
    [Abstract] [Full Text] [Related]

  • 38. Diffusion magnetic resonance imaging in multiple sclerosis.
    Hygino da Cruz LC, Batista RR, Domingues RC, Barkhof F.
    Neuroimaging Clin N Am; 2011 Feb 09; 21(1):71-88, vii-viii. PubMed ID: 21477752
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
    Zhou F, Shiroishi M, Gong H, Zee CS.
    J Magn Reson Imaging; 2010 Apr 09; 31(4):789-95. PubMed ID: 20373421
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.